⌘K
Loading ticker…
As of 2026-09-10, Lakefront Biotherapeutics American Depositary Shares (LKFT) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 15.8 (Defensive). Sector: Healthcare, ranked 3 of 11. Average daily range 2.1%, relative volume 0.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
LKFT appears in 1 ETF as of Jun 2026: IBB at 0.10% weight, $9M notional.
Held by 7 ETFs · $12M across latest filings · largest weight 1.19% (SBIO).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| IBB | 0.10% | $9M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Not enough history to compute monthly seasonality for LKFT.